Intuitive Surgical forward PE ISRG
Share price divided by analysts' consensus earnings for the next twelve months, since 2004.
- Today, Oct 23, 2026
- 37.5×
- 10-year median
- 52.8×
- Against its 10-year history
- 13th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 22.8× to 79.5×
- Peer median
- 22.0×
Intuitive Surgical's forward PE is 37.5× as of Oct 23, 2026.
That is below its ten-year median of 52.8×, lower than on 87% of days in the last ten years.
Over that time it ranged from 22.8× in Nov 2016 to 79.5× in Jan 2025.
The median for 4 medical instruments and supplies stocks of a similar size is 22.0×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 37.5× | 29.3× | 61.4× |
| 2025 | 60.5× | 48.3× | 79.5× |
| 2024 | 71.8× | 53.0× | 73.8× |
| 2023 | 55.4× | 41.4× | 62.7× |
| 2022 | 51.1× | 37.3× | 69.2× |
| 2021 | 76.6× | 54.2× | 77.8× |
| 2020 | 66.3× | 47.2× | 77.8× |
| 2019 | 69.5× | 39.1× | 69.5× |
| 2018 | 40.1× | 38.0× | 51.4× |
| 2017 | 43.3× | 23.3× | 47.2× |
| 2016 | 23.2× | 22.8× | 35.3× |
| 2015 | 32.3× | 27.3× | 33.9× |
| 2014 | 34.0× | 24.6× | 36.0× |
| 2013 | 28.0× | 26.7× | 42.3× |
| 2012 | 33.7× | 32.9× | 41.5× |
| 2011 | 36.7× | 27.9× | 36.7× |
| 2010 | 26.8× | 25.8× | 45.3× |
| 2009 | 42.5× | 18.2× | 42.8× |
| 2008 | 25.4× | 24.6× | 70.2× |
| 2007 | 44.2× | 15.3× | 48.0× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Intuitive Surgical's size, closest first, today.
| Company | Forward PE |
|---|---|
| ISRGIntuitive Surgical | 37.5× |
| BDXBecton, Dickinson and | 15.1× |
| MDLNMedline | 23.2× |
| RMDResMed | 20.8× |
| WSTWest Pharmaceutical Services | 42.2× |
| Peer median | 22.0× |
Where Intuitive Surgical ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Intuitive Surgical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.